Bioqual Past Earnings Performance
Past criteria checks 0/6
Bioqual's earnings have been declining at an average annual rate of -7.2%, while the Life Sciences industry saw earnings growing at 16.4% annually. Revenues have been growing at an average rate of 11.8% per year.
Key information
-7.2%
Earnings growth rate
-7.2%
EPS growth rate
Life Sciences Industry Growth | 21.5% |
Revenue growth rate | 11.8% |
Return on equity | -1.2% |
Net Margin | -0.7% |
Last Earnings Update | 30 Nov 2023 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses BreakdownBeta
How Bioqual makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Nov 23 | 62 | 0 | 12 | 0 |
31 Aug 23 | 62 | 0 | 12 | 0 |
31 May 23 | 63 | 1 | 12 | 0 |
28 Feb 23 | 65 | 3 | 11 | 0 |
30 Nov 22 | 68 | 5 | 11 | 0 |
31 Aug 22 | 66 | 5 | 10 | 0 |
31 May 22 | 66 | 5 | 10 | 0 |
28 Feb 22 | 64 | 5 | 10 | 0 |
30 Nov 21 | 60 | 6 | 10 | 0 |
31 Aug 21 | 58 | 6 | 10 | 0 |
31 May 21 | 58 | 6 | 9 | 0 |
28 Feb 21 | 55 | 5 | 9 | 0 |
30 Nov 20 | 54 | 5 | 8 | 0 |
31 Aug 20 | 51 | 5 | 8 | 0 |
31 May 20 | 46 | 4 | 8 | 0 |
29 Feb 20 | 44 | 4 | 7 | 0 |
30 Nov 19 | 43 | 4 | 7 | 0 |
31 Aug 19 | 40 | 4 | 7 | 0 |
31 May 19 | 39 | 3 | 7 | 0 |
28 Feb 19 | 38 | 3 | 4 | 0 |
30 Nov 18 | 36 | 3 | 4 | 0 |
31 Aug 18 | 37 | 4 | 4 | 0 |
31 May 18 | 36 | 4 | 3 | 0 |
28 Feb 18 | 35 | 3 | 3 | 0 |
30 Nov 17 | 36 | 3 | 3 | 0 |
31 Aug 17 | 36 | 4 | 3 | 0 |
31 May 17 | 37 | 4 | 3 | 0 |
28 Feb 17 | 37 | 4 | 3 | 0 |
30 Nov 16 | 37 | 4 | 3 | 0 |
31 Aug 16 | 36 | 4 | 3 | 0 |
31 May 16 | 33 | 3 | 3 | 0 |
29 Feb 16 | 31 | 2 | 3 | 0 |
30 Nov 15 | 29 | 2 | 3 | 0 |
31 Aug 15 | 29 | 2 | 3 | 0 |
31 May 15 | 29 | 2 | 3 | 0 |
28 Feb 15 | 29 | 2 | 3 | 0 |
30 Nov 14 | 26 | 1 | 3 | 0 |
31 Aug 14 | 23 | 1 | 3 | 0 |
31 May 14 | 22 | 1 | 3 | 0 |
28 Feb 14 | 19 | 1 | 3 | 0 |
30 Nov 13 | 19 | 0 | 3 | 0 |
31 Aug 13 | 19 | 0 | 3 | 0 |
31 May 13 | 20 | 0 | 3 | 0 |
Quality Earnings: BIOQ is currently unprofitable.
Growing Profit Margin: BIOQ is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BIOQ is unprofitable, and losses have increased over the past 5 years at a rate of 7.2% per year.
Accelerating Growth: Unable to compare BIOQ's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: BIOQ is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-9.3%).
Return on Equity
High ROE: BIOQ has a negative Return on Equity (-1.19%), as it is currently unprofitable.